511 results on '"Oh, Dong Joo"'
Search Results
2. Impact of Statin Use on Development of New-Onset Diabetes Mellitus in Asian Population
3. Long-Term Safety and Efficacy of Pitavastatin in Patients With Acute Myocardial Infarction (from the Livalo Acute Myocardial Infarction Study [LAMIS])
4. Usefulness of Coronary Pressure Measurement for Functional Evaluation of Drug-Eluting Stent Restenosis
5. Comparison of Frequency of Coronary Spasm in Korean Patients With Versus Without Myocardial Bridging
6. Impact of Periprocedural Myocardial Infarction Following Chronic Total Occlusion Interventions on Mid-term Angiographic and 2-year Clinical Outcomes
7. The Impact of Hyperuricemia on 24-month Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents
8. The Impact of the Hs CRP on 2-year Clinical Outcomes Following Percutaneous Coronary Intervention with Drug-eluting Stents in Asian Population
9. Six-month Angiographic and 2-years Clinical Outcomes Between IVUS Versus No IVUS Guided Chronic Total Occlusion Intervention with Drug-eluting Stents
10. Restenotic Stented Versus De Novo Chronic Total Occlusion Outcomes Following Successful Intervention with Drug-Eluting Stents
11. Impact of Coronary Artery Spasm on Development of New-onset Diabetes Mellitus in Asian Population
12. Impact of Chronic Beta Blocker Therapy on Development of New-onset Diabetes Mellitus in Asian Population
13. Impact of Chronic Calcium Channel Blocker Therapy on Development of New-onset Diabetes Mellitus in Asian Population
14. Impact of Chronic Total Occlusion Intervention in Small Target Vessels on Six-month Angiographic and Two-year Clinical Outcomes with Drug-eluting Stents
15. Predictors Associated with Ischemic ECG Changes During Acetylcholine Provocation Test; Is Uric Acid Can Be an Useful Biomarker for Significant Coronary Endothelial Dysfunction?
16. Comparison Between Long Versus Short Chronic Total Occlusion Intervention with Drug-eluting Stents; Six-month Angiographic and 2-Years Clinical Outcomes
17. Impact of Multivessel Disease in Patients with Chronic Total Occlusion on Six-month Angiographic and Two-year Clinical Outcomes
18. Risk Factors, Biomarkers, and Echocardiographic Parameters According to Coronary Artery Calcium Scoring (Agatstone) Measured by 64-channel Multidetector Computed Tomography
19. Zotarolimus-eluting Versus Everolimus-eluting Stents for Treatment of Unprotected Left Main Coronary Artery Stenosis: 2-year Follow-up of Single-center Registry
20. Crushing Versus Kissing Stenting in ‘Real World’ Unprotected Left Main Bifurcation Intervention with Drug-eluting Stents
21. Multivessel Chronic Total Occlusion Outcomes Can Be Different with Single Vessel Chronic Total Occlusion?
22. Impact of Hyperuricemia on Coronary Artery Spasm as Assessed with Intracoronary Acetylcholine Provocation Test
23. Association of N-terminal-Pro-B-type Natriuretic Peptide Levels and 2 years Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents in Asian Populations
24. Impact of Chronic Diuretics Therapy on Development of New-onset Diabetes Mellitus in Asian Population
25. Impact of Ischemic EKG Changes During the Acetylcholine Provocation Test on 12-month Clinical Outcomes in Patients with Vasospastic Angina
26. Left Ventricular Mass Index and Septal E/E' Ratio Is Associated with Coronary Artery Calcium Score Severity in Subjects with Normal Left Ventricular Ejection Fraction
27. Predictors Associated with Major Adverse Cardiac Events Following Successful Chronic Total Occlusion Intervention with Drug-eluting Stents
28. AS-176 Elective versus Bailout Stenting Outcomes Following Unprotected Left Main Intervention with Drug-eluting Stents
29. AS-187: Impact of Lesion Length on Chronic Total Occlusion Intervention Outcomes
30. AS-191: Impact of Occlusion Duration on Angiographic and Clinical Outcomes following Chronic Total Occlusion Intervention with Drug-eluting Stents
31. AS-261: Low versus High Acetylcholine Dose Response in Patients with Vasospastic Angina
32. AS-209 Newer Generations versus First Generation Drug-Eluting Stents in Small Vessel Disease
33. AS-278: Combined Intracoronary Ergnovine and Acetylcholine Provocation Test for Assessment of Significant Coronary Artery Spasm
34. AS-227 Relationship between Alcohol Drinking Pattern and Vasospastic Angina
35. AS-217 “Real-World” Comparison of 2-year Clinical Outcomes Between First Generation and Second Generation Drug-eluting Stents in Asian Population
36. AS-263: Serum Adipocyte-Specific Fatty Acid-Binding Protein is a Predictable Marker of Coronary Artery Disease and Diabetes Mellitus
37. AS-265: Impact of Increased Basal Tonicity of Coronary Artery on Acetylcholine Provocation Test Result in Korean Patient with Chest Pain
38. AS-262: Efficacy and Safety of Adjuvant Proximal Balloon Inflation Comprising Stent Proximal Edge for Full Expansion of the Stent by Stent Balloon
39. AS-232 The Effect of Anemia in Primary Percuataneou Coronary Intervention for Acute Myocardial Infarction on 6-Month Angiographic and 1-Year Clinical Outcomes
40. AS-189: Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients with Chronic Renal Insufficiency
41. AS-210 The Impact of Low Level of High-Density Lipoprotein Cholesterol on Six-Month Angiographic and 2-year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents
42. AS-205 Comparisons of Everolimus- and Paclitaxel-Eluting Stents in Patients with Acute Myocardial Infarction
43. AS-225 Impact of Alcohol on Coronary Artery Spasm as Assessed with Intracoronary Acetylcholine Provocation Test
44. AS-294: Oxygen Saturation Measured by Pulse Oxymeter during Radial Compression May Different According to Different Coronary Risk Factors Following Transradial Intervention
45. AS-163 The Impact of Bifurcation Lesions on 6-month Angiographic and Long term Clinical Outcomes in Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents
46. AS-060 Twelve-Months Clinical Efficacy and Safety of Zotarolimus (Endeavor ResoluteTM)- versus Platinum Chromium based Everolimus-Eluting Stents (Promus ElementTM) in Asian Patients
47. AS-211 The Influence of Post Percutaneous Coronary Intervention Activated Clotting Time Level on In-Hospital and Short-Term Clinical Outcomes in the Drug-Eluting Stent Era
48. AS-228 Effect of Left Ventricular Ejection Fraction on 2-Year Clinical Cutcomes in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention with Drug-Eluting Stents
49. AS-188: Two-Year Clinical Cutcomes of in ‘Real world’, Chronic Total Occlusive Lesions; Comparison of Sirolimus-Eluting and Paclitaxel-Eluting stents
50. AS-134: Impact of Left Anterior Descending Artery Lesion versus Non-Left Anterior Descending Artery Lesion on 1-Year Clinical Outcomes in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.